Informed Genomics
Informed Genomics is a Birmingham, UK-based private biotechnology company focused on earlier cancer diagnosis, personalized treatments, and improved patient outcomes through genomic-driven approaches.
- Company typePrivate
- Founded-
- HeadquartersBirmingham, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Informed Genomics does
Informed Genomics is a private biotechnology company headquartered in Birmingham, United Kingdom, focused on earlier diagnosis, personalized treatments, and improved outcomes for cancer patients. The firm operates within the oncology diagnostics and precision medicine space, positioning itself across the cancer care continuum from detection through treatment selection. The company is registered at informedgenomics.com and operates with a headcount of 11-50 employees, placing it in the early-to-mid stage small-cap biotech category typical of UK clinical-stage diagnostics developers and academic spinouts.
Its Birmingham location situates Informed Genomics within a recognized UK life sciences and genomics cluster. However, specific operational details are not documented in the available data: no proprietary product lines, assay platforms, or underlying technology architectures are described; no laboratory certifications, regulatory clearances (such as UKCA, CE-IVD, MHRA, or FDA), or clinical-grade validation milestones are listed; and no management team, founders, or scientific advisory board members are identified.
The company's revenue model, pricing structure, customer base, ownership structure, funding history, and go-to-market approach are all unconfirmed in the input sources, with primary website content inaccessible due to verification and CAPTCHA blocks. This data gap materially limits visibility into commercial traction, capital structure, and strategic positioning, leaving the firm's current stage of development, pipeline status, and market entry progress undetermined from publicly available signals.
Informed Genomics firmographics
Firmographics- Name
- Informed Genomics
- Website
- https://informedgenomics.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Informed Genomics is a Birmingham, UK-based private biotechnology company focused on earlier cancer diagnosis, personalized treatments, and improved patient outcomes through genomic-driven approaches.
- Ownership category
- akta.pro rank
Informed Genomics industry classification
Industry- Product category
- Cancer Genomics Diagnostics
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Genomic Profiling & Sequencing-Based Precision Medicine (HLAAANAA)
- akta.pro secondary industries
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
Keywords
Where Informed Genomics is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Informed Genomics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
Informed Genomics product offering
Product offeringCore offering
Informed Genomics is a biotechnology company that provides genomics-based cancer diagnostics focused on earlier cancer diagnosis and the selection of personalized treatments. Its offering supports clinicians and patients in oncology by combining molecular and genomic testing to inform therapy decisions and improve clinical outcomes.
Differentiator
Problem solved
Functional benefit
Companies that use Informed Genomics
Customer profileIdeal customer profiles1 record
Informed Genomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Informed Genomics competitors and assessment
Company assessmentBroad incumbents
- Exact Sciences (Genomic Health): Oncology diagnostics leader (Oncotype DX, Cologuard) with strong cancer genomics heritage and US commercial scale. Comparable to Informed Genomics on cancer genomics and earlier diagnosis but operates a fully commercialized franchise.
- Tempus Labs: AI-enabled precision medicine company with extensive oncology genomic profiling and data products. Broad incumbent offering comparable cancer molecular testing plus data/analytics that Informed Genomics' personalization thesis would compete against.
- Foundation Medicine: Roche-owned leader in comprehensive genomic profiling for solid tumors (FoundationOne CDx). Directly comparable to Informed Genomics' oncology genomics profiling mission but operates at vastly greater scale with FDA-approved companion-diagnostic claims.
- NeoGenomics: US-based oncology-focused clinical laboratory offering a wide menu of cancer diagnostic tests including NGS profiling. Comparable to Informed Genomics as a cancer-focused diagnostic lab, but at much larger scale and broader test menu.
Direct peers
- Personalis: Genomics company specializing in ImmunoID Next and other cancer genomics products for biopharma and clinicians. Direct peer in oncology genomic profiling, though more biopharma-services oriented.
- SOPHiA Genetics: Switzerland-based genomics informatics and diagnostics company with cancer testing (including hereditary cancer and solid-tumor applications). Comparable to Informed Genomics on combining NGS and analytics for cancer diagnosis and personalized treatment, with broader European footprint.
- Guardant Health: US-based liquid-biopsy and tissue genomics company (Guardant360, Guardant Reveal) focused on cancer diagnosis, treatment selection, and recurrence monitoring. Closest direct peer to Informed Genomics' "earlier diagnosis and personalized treatment" positioning for cancer.
- Caris Life Sciences: Provides MI Profile molecular profiling and Caris Assure liquid biopsy for oncology. Directly competes with Informed Genomics on cancer genomic profiling and personalized treatment selection.
Regional players
- Inivata: Cambridge, UK-based liquid biopsy company (acquired by NeoGenomics) focused on circulating tumor DNA for cancer treatment selection and monitoring. Closest geography-matched peer to Informed Genomics in the UK oncology genomics space.
Emerging players
- Nonacus: UK-based genomics company providing NGS products and services for liquid biopsy and cancer research. Comparable to Informed Genomics as a UK-headquartered emerging player in cancer genomics, though more research-tools oriented.
Market position
Competitive moat1 record
Key highlights3 records
Customer concentration
Informed Genomics social profiles
Digital presenceInformed Genomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Informed Genomics leadership team
Management profileNumber of profiles
Informed Genomics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Informed Genomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Informed Genomics
What does Informed Genomics do?
Informed Genomics is a biotechnology company that provides genomics-based cancer diagnostics focused on earlier cancer diagnosis and the selection of personalized treatments. Its offering supports clinicians and patients in oncology by combining molecular and genomic testing to inform therapy decisions and improve clinical outcomes.
When was Informed Genomics founded?
Informed Genomics was founded in -1. It employs 11 to 50 people.
Where is Informed Genomics based?
Informed Genomics is headquartered in Birmingham, United Kingdom, in the Europe region.
Who are Informed Genomics's main competitors?
Broad incumbents on record are Exact Sciences (Genomic Health), Tempus Labs, Foundation Medicine and NeoGenomics. Direct peers are Personalis, SOPHiA Genetics, Guardant Health and Caris Life Sciences. Inivata is listed as a regional player. Nonacus is listed as an emerging player.
Does Informed Genomics have an API?
No public API is recorded for Informed Genomics.
What industry is Informed Genomics in?
Informed Genomics's product category is Cancer Genomics Diagnostics. Its primary akta.pro industry code is HLAAANAA, Genomic Profiling & Sequencing-Based Precision Medicine, with a secondary code of HLAFAMAE, Molecular Diagnostics & Genomics Laboratories. Its NAICS code is 621511 and its SIC code is 8071.